CA00288U1066 - Common Stock
ABCL earnings call for the period ending September 30, 2024.
Stay updated with the stocks that are on the move in today's after-hours session.
ABCL earnings call for the period ending June 30, 2024.
The Baker brothers are billionaires with a successful track record in the biopharmaceutical industry.
Wall Street analysts say this drug developer can more than double your money.
If you don’t mind taking a risk in the discount section, these undervalued Nasdaq stocks just might surprise some folks.
ABCL earnings call for the period ending March 31, 2024.
ABCL stock results show that AbCellera Biologics beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.